Organizers of the Third Immunoinformatics and Computational Immunology Workshop (ICIWÂ 2012)Â have announced a call for papers for this year’s event to be held in conjunction with the ACM International Conference on Bioinformatics and Computational Biology (ACM-BCB2012). The conference is scheduled for October 7-10, 2012 in Orlando, FL. Naturally emerging or reemerging diseases pose some of the [...]
Attention fish farmers: We are working on fish vaccines!
Fish farming is an important source of nutrition for the global protein market, but the farms are plagued by infectious diseases. At URI and EpiVax, we are developing a model for predicting fish T cell epitopes which will allow us to screen fish pathogens for candidate vaccine antigens. This model is being applied to pathogens [...]
TRIAD Toolkit Workshop
TRIAD Toolkit Workshop & Pilot Project Program Vaccine Design Training Using Immunoinformatics The TRIAD program based at the University of Rhode Island’s Institute for Immunology and Informatics (iCubed) will be holding its semiannual workshop on May 29 which focuses on vaccine design using immunoinformatics and immunological techniques. TRIAD, or Translational Immunology Research and Accelerated [Vaccine] Development, is [...]
De Groot and Spero to be honored by RIWHE
Dr. Annie De Groot and Dr. Denice Spero will be honored this Friday, April 27 for their contributions to higher education during an award ceremony presented by The ACE Network: Rhode Island Women in Higher Education (RIWHE). The ceremony, to be held on the campus of Salve Regina University, is part of the organization’s 9th [...]
Dr. William Golde to lecture at Seminar Series
iCubed is excited to welcome Dr. William Golde, a microbiologist from the Plum Island Animal Disease Center, as the next speaker in our Seminar Series. Please join us all on Monday, April 23 at 4pm for his talk titled “Analysis of Vaccine Performance in the 21st Century: The Impact of Studies in Livestock Species.” The [...]
EpiVax Inc. to receive $1.5 million from National Institutes of Health
Congratulations to EpiVax, Inc. which has been awarded a new SBIR Phase II grant from the National Institutes of Health totaling $1.5 million. EpiVax anticipates receiving an additional SBIR award of approximately $775,000 within the next few months, bringing the total to over $2.25 million. The funding will be dedicated to helping move forward treatment for [...]
Connect with us
Subscribe to our e-mail newsletter to receive updates.
